T cells that are naturally tolerant to cartilage-derived type II collagen are involved in the development of collagen-induced arthritis

Arthritis Research

Volumn 2, Issue 4, 2000, Pages 315-326

  Malstrom V ^a   Backlund J ^a   Jansson, L ^a   Kihlberg, J ^a   Holmdahl, R ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Autoimmunity; Rheumatoid arthritis; T lymphocytes; Tolerance; Transgenic

Indexed keywords

COLLAGEN TYPE 2; EPITOPE; GAMMA INTERFERON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; B LYMPHOCYTE; CARTILAGE; CELL TRANSFER; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; DISEASE PREDISPOSITION; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PROTEIN GLYCOSYLATION; T LYMPHOCYTE; THYMECTOMY; THYMUS; TRANSGENIC MOUSE;

ANIMALS; ARTHRITIS; CARTILAGE; CELLS, CULTURED; COLLAGEN; GLYCOSYLATION; IMMUNOGLOBULIN G; LYMPH NODES; MICE; MICE, TRANSGENIC; PEPTIDES; T-LYMPHOCYTES;

EID: 0034468364     PISSN: 14659905     EISSN: None     Source Type: Journal    
DOI: 10.1186/ar106     Document Type: Article

References (65)

1. Expression of a transgenic class II Ab gene confers susceptibility to collagen-induced arthritis
2. Identification of an immunodominant type-II collagen peptide recognized by T cells in H-2q mice: Self tolerance at the level of determinant selection
3. Characterization of the T cell determinants in the induction of autoimmune arthritis by bovine alpha 1(II)-CB11 in H-2q mice
4. Type II collagen autoimmunity in animals and provocations leading to arthritis
5. Definition of MHC and T cell receptor contacts in the HLA-DR4 restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice
6. An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen
7. Pristane-induced arthritis in rats: A new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes
8. Localization of quantitative trait loci regulating adjuvant-induced arthritis in rats: Evidence for genetic factors common to multiple autoimmune diseases
9. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme
10. Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I
11. A wide spectrum of collagen vascular and autoimmune diseases in transgenic rats carrying the env-pX gene of human T lymphocyte virus type I
12. Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis
13. Use of soluble peptide-DR4 tetramers to detect synovial T cells specific for cartilage antigens in patients with rheumatoid arthritis
14. Systemic versus cartilage-specific expression of a type II collagen-specific T-cell epitope determines the level of tolerance and susceptibility to arthritis
15. B cell-deficient mice do not develop type II collagen-induced arthritis (CIA)
16. Association of pepsin with type II collagen (CII) breaks control of CII autoimmunity and triggers development of arthritis in rats
17. New fluorescent dyes for lymphocyte migration studies. Analysis by flow cytometry and fluorescence microscopy
18. Epitope glycosylation plays a critical role for T cell recognition of type II collagen in collagen-induced arthritis
19. T cell responses to human type II collagen in patients with rheumatoid arthritis and healthy controls
20. Enhanced T cell proliferative response to type II collagen and synthetic peptide CII (255-274) in patients with rheumatoid arthritis
21. *0401 and DQ8
22. Transgenic mouse models of rheumatoid arthritis
23. Local anti-type II collagen antibody production in rheumatoid arthritis synovial fluid. Evidence for an HLA-DR4-restricted IgG response
24. Antibodies to type II collagen and HLA disease susceptibility markers in rheumatoid arthritis
25. Another pathway towards arthritis
26. On the thymus in the differentiation of 'H-2 self recognition' by T-cells: Evidence for dual recognition
27. Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex
28. Targeted complementation of MHC class II deficiency by intrathymic delivery of recombinant adenoviruses
29. T cells can be activated by peptides that are unrelated in sequence to their selecting peptide
30. Ablation of 'tolerance' and induction of diabetes by virus infection in viral antigen transgenic mice
31. Differential requirements for survival and proliferation of CD8 naive or memory T cells
32. Peripheral selction of T cell repertoires; the role of continous thymus output
33. Peripheral tolerance as a multi-step mechanism
34. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity
35. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice
36. Type II collagen induced arthritis in mice. I. Major histocompatibility complex (I-region) linkage and antibody correlates
37. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis
38. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis
39. *0401-restricted T cell response to type II collagen
40. *0401) complexed with a peptide from human collagen II
41. *0401) transgenic mice by immunization with human and bovine type II collagen
42. Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4
43. T lymphocytes in collagen II-induced arthritis in mice. Characterization of arthritogenic collagen II-specific T cell lines and clones
44. Treatment of a newly established transgenic model of chronic arthritis with nondepleting anti-CD4 monoclonal antibody
45. Mouse type II collagen gene. Complete nucleotide sequence, exon structure, and alternative splicing
46. Type II collagen in cartilage evokes peptide-specific tolerance and skews the immune response
47. MHC interaction and T cell recognition of carbohydrates and glycopeptides
48. Specificity of glycopeptide-specific T cells
49. Recognition of carbohydrate by major histocompatibility complex class I-restricted, glycopeptide-specific cytotoxic T lymphocytes
50. Immunization with glycosylated Kb-binding peptides generates carbohydrate-specific, unrestricted cytotoxic T cells
51. Carbohydrate and peptide specificity of MHC class II-restricted T cell hybridomas raised against an O-glycosylated self peptide
52. T cell recognition of carbohydrates on type II collagen
53. Antigen processing and presentation of a naturally glycosylated protein elicits major histocompatibility complex class II-restricted, carbohydrate-specific T cells
54. Nature of the collagen synthesized by a transplanted chondrosarcoma
55. Analysis of type II collagen reactive T cells in the mouse. I. Different regulation of autoreactive versus non-autoreactive anti-type II collagen T cells in the DBA/1 mouse
56. T cells recognize a glycopeptide derived from type II collagen in a model for rheumatoid arthritis
57. High antibody response to autologous type II collagen is restricted to H-2q
58. Macrophages but not dendritic cells present collagen to T-cells
59. Processing and presentation of type II collagen, a fibrillar autoantigen, by H-2q antigen-presenting cells
60. The dendritic cell system and its role in immunogenicity
61. + T cell pools
62. T cell memory is short-lived in the absence of antigen
63. Clonal expansion versus functional clonal inactivation: A costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy
64. Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial super-antigen
65. Genetics of susceptibility to pristane-induced plasmacytomas in BALB/cAn: Reduced susceptibility in BALB/cJ with a brief description of pristane-induced arthritis